![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Amgen to Test Psoriasis Drug Otezla as Possible COVID-19 Treatment
Amgen to Test Psoriasis Drug Otezla as Possible COVID-19 Treatment
Amgen plans to test its blockbuster psoriasis drug Otezla (apremilast) as a possible COVID-19 treatment.
CEO Robert Bradway said the psoriasis drug could help prevent respiratory stress in late-stage COVID-19 patients. The company expects to begin trials of the drug in coming weeks. The company is looking to study the drug in multiple scenarios.
Upcoming Events
-
18Jul
-
21Oct